Manuscripts and Plain Language
Summaries. Accelerated.
Turn complex clinical data into clear, compliant, publication-ready content.
In days, not months.
Scientific innovation demands speed. Sorcero combines medically tuned Agentic AI
with expert review to deliver accuracy, speed, and consistency you can trust.
Proven impact.
Redefining the speed and standard of scientific content generation.
Days
instead of months.
From source to manuscript draft.
18x
higher engagement.
From patient & non-specialist PLS.
600%
improved readability.
Compared to manually drafted PLS.
Intelligence built
for science.
Sorcero goes beyond Generic AI summarization.
Our platform is purpose-built for the nuance of Life Sciences, utilizing Agentic AI to ingest specific document structures—CSRs, Protocols, and TFLs— and applying regulatory templates to generate precision drafts.
Built-in verification checks and ontological models ensure the AI never invents facts.
Expert Review
Every summary is backed by Sorcero’s in-house SMEs, keeping a human in the loop for quality assurance.
Strategic Context
Content that ensures the summary aligns with your organization's scientific narrative, not just the text on the page.
Manuscript Drafts.
Ready in less than a week.
Reduce Time-To-Publication without sacrificing integrity. Sorcero delivers Foundational
Drafts powered by Agentic AI and mandatory Subject-Matter-Expert review.
Accelerate the process from source to draft in less than a week.
Phase 3 (Superiority, Non-Inferiority) Trials: Structured handling of primary/secondary endpoints.
Patient Reported Outcomes (PRO): Patient perspective compliant with CONSORT-PRO.
Real-World Evidence (RWE): Descriptive, Exploratory, and Causative studies alignment with RECORD-PE.
Full adherence to CONSORT (2025), STROBE, ICMJE, and GPP 2022 guidelines.
Our DAIS™ (Definitive-AI-Scoring) Rubrics were built with 3 top-ten Pharma companies and leading agencies.
We don't just guess what "good" looks like, we validated it with the industry.
PLS for Every Audience.
REGULATORY COMPLIANCE
Plain Language Trial Summaries (PLTS)
The EU Clinical Trials Regulation (EU CTR 536/2014) mandates lay summaries for every CSR. Manual drafting takes 2-3 weeks, creating a compliance backlog.
Sorcero automates the drafting of PLTSs that are fully compliant with EU CTR Annex V and promotional language prohibitions.
Result: Go from source ingestion to compliant draft in days. Optimized for Regulators (EMA, FDA), Patients, and HCPs.
JOURNAL SUBMISSION
Abstract Plain Language Summaries (aPLS)
Journals now require plain language abstracts. Treating them as an afterthought delays submission timelines.
Sorcero provides submission-ready aPLS that consistently meets readability thresholds (FDA/EMA standards) instantly.
Result: Reduced submission
delays and freed-up medical
writers.
INTERNAL STRATEGY
Stakeholder Plain Language Summaries (sPLS)
Internal teams (Commercial, C-Suite, Regulatory) struggle to digest new clinical data quickly because it is too dense and siloed.
Sorcero generates summaries tailored for internal non-specialists, highlighting business impact, strengths, and limitations.
Result: Faster cross-functional decision-making and consistent messaging.
MAXIMUM ENGAGEMENT
Video Plain Language Summaries (vPLS)
Video is the most engaging medium, but traditional production is manual, slow, and prohibitively expensive.
Sorcero generates scripts, voiceovers (patient-centric tones), and visuals that comply with lay summary requirements.
Result: Maximum accessibility
through a balanced mix of
visuals, audio, and text—at a
fraction of the cost.
A New Validation Standard.
Trust is engineered into the process. The Sorcero Validation Toolsetautomates quality control with industry-first precision.
Promotional Language Checker
Flag promotional language in line with EU CTR guidelines for any document type.
Data QC Validator
Immediate, automated data quality control summaries for manuscripts and other written content.
DAIS™ Rubrics
Industry-standard scoring (e.g., DAIS-3, DAIS-PLTS) applied to all Sorcero outputs.
Complex Trial Validation
Generic validators fail on complex designs. Our DAIS™ Rubrics include "Automatic Failure" checks specific to trial types, and
comprehensive multi-domain criteria. We don't just check for a margin; we check for its justification.
This ensures you never claim "non-inferiority" based on an arbitrary or post-hoc threshold.
Private. Secure. Compliant.
In pharma, accuracy isn't optional.
It's the law.
Resources
Go deeper.

Read our AI validation studies published with industry partners, including UCB, Moderna, and AstraZeneca.

.png?width=300&name=Evidence%20(1).png)
Learn how the future of commercialization will be driven by superior medical intelligence.


A comprehensive guide to navigating the complexities of compliance, privacy, and trust in medical AI.

